Jianan Li|Wenguang Xia|Chao Zhan|Shouguo Liu|Zhifei Yin|Jiayue Wang|Yufei Chong|Zheng Cheng|Xiaoming Fang|Wei Cheng|Jan D. Reinhardt
A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial
Jiangsu Province Hospital|Nanjing Medical University|Integrated Chinese Medicine (China)|Hubei Provincial Women and Children's Hospital|Jiangsu Province Hospital|Nanjing Medical University|Jiangsu Province Hospital|Nanjing Medical University|Jiangsu Province Hospital|Nanjing Medical University|Integrated Chinese Medicine (China)|Hubei Provincial Women and Children's Hospital|Integrated Chinese Medicine (China)|Hubei Provincial Women and Children's Hospital|Swiss Paraplegic Research|University of Lucerne|Sichuan University
investigate superiority telerehabilitation programme covid19 tereco rehabilitation regard exercise capacity lower limb muscle strength lms pulmonary function healthrelated quality life hrqol dyspnoeaparallelgroup randomised controlled trial 11 block randomisationthree major hospitals jiangsu hubei provinces china120 formerly hospitalised covid19 survivors remaining dyspnoea complaints randomised 61 allocated control 59 terecounsupervised homebased 6week exercise programme comprising breathing control thoracic expansion aerobic exercise lms exercise delivered via smartphone remotely monitored heart rate telemetryprimary outcome 6 min walking distance 6mwd metres secondary outcomes squat time seconds pulmonary function assessed spirometry hrqol measured short form health survey12 sf12 mmrcdyspnoea outcomes assessed 6 weeks posttreatment 28 weeks followupadjusted betweengroup difference change 6mwd 6545 95 ci 438 871 p0001 posttreatment 6862 95 ci 4639 9085 p0001 followup treatment effects lms 2012 95 ci 1234 279 p0001 posttreatment 2223 95 ci 1424 3021 p0001 followup group differences found lung function except posttreatment maximum voluntary ventilation increase sf12 physical component greater tereco group treatment effects estimated 379 95 ci 124 635 p0004 posttreatment 269 95 ci 006 532 p0045 followupthis trial demonstrated superiority tereco rehabilitation 6mwd lms physical hrqolchictr2000031834